Sandaracopimaric acid
Product Specifications
UNSPSC Description
Sandaracopimaric acid is a diterpenoid with anti-inflammatory effect. Sandaracopimaric acid reduces the contraction of phenylephrine-induced pulmonary arteries with an EC50 of 43.93 μM[1][2].
Target Antigen
GABA Receptor
Type
Natural Products
Related Pathways
Membrane Transporter/Ion Channel;Neuronal Signaling
Applications
COVID-19-immunoregulation
Field of Research
Inflammation/Immunology; Cardiovascular Disease
Assay Protocol
https://www.medchemexpress.com/sandaracopimaric-acid.html
Purity
98.86
Solubility
DMSO : 3.5 mg/mL (ultrasonic;warming)
Smiles
O=C([C@]1(C)CCC[C@]2(C)[C@@]3([H])CC[C@](C)(C=C)C=C3CC[C@@]12[H])O
Molecular Weight
302.45
References & Citations
[1]Wenyan Gao, et al. Dehydroabietic acid isolated from Commiphora opobalsamum causes endothelium-dependent relaxation of pulmonary artery via PI3K/Akt-eNOS signaling pathway. Molecules. 2014 Jun 23;19(6):8503-17.|[2]Masao Takei, et al. Diterpenes drive Th1 polarization depending on IL-12. Int Immunopharmacol. 2008 Nov;8(11):1602-8.
Shipping Conditions
Blue Ice
Storage Conditions
-20°C (Powder, sealed storage, away from moisture)
Product Datasheet
http://file.medchemexpress.com/batch_PDF/HY-133594/Sandaracopimaric-acid-DataSheet-MedChemExpress.pdf
Product MSDS
http://file.medchemexpress.com/batch_PDF/HY-133594/Sandaracopimaric-acid-SDS-MedChemExpress.pdf
Clinical Information
No Development Reported
CAS Number
471-74-9
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
